Docusign (NASDAQ:DOCU) Price Target Cut to $65.00 by Analysts at JPMorgan Chase & Co.

Docusign (NASDAQ:DOCU) had its target price reduced by JPMorgan Chase & Co. from $78.00 to $65.00 in a report published on Wednesday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Several other equities analysts have also recently weighed in on DOCU. HSBC set a $53.00 price objective on shares of Docusign in a research report on Friday, February 13th. Bank of America decreased their target price on Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Evercore lowered their price target on Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a report on Friday, December 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Finally, Robert W. Baird reduced their price objective on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research note on Wednesday. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $66.67.

Docusign Trading Up 2.9%

DOCU stock opened at $48.90 on Wednesday. Docusign has a one year low of $40.16 and a one year high of $94.67. The firm has a market capitalization of $9.79 billion, a PE ratio of 33.04, a P/E/G ratio of 2.07 and a beta of 1.03. The firm has a 50-day moving average of $50.69 and a two-hundred day moving average of $64.35.

Docusign (NASDAQ:DOCU) last released its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.70%. The business had revenue of $836.86 million for the quarter, compared to the consensus estimate of $828.23 million. During the same period last year, the firm posted $0.86 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. On average, equities research analysts anticipate that Docusign will post 1.17 earnings per share for the current year.

Docusign announced that its Board of Directors has initiated a share repurchase plan on Tuesday, March 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to buy up to 21% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Insider Activity at Docusign

In related news, CRO Paula Hansen sold 6,000 shares of the stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the sale, the executive directly owned 68,970 shares in the company, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Blake Jeffrey Grayson sold 6,500 shares of Docusign stock in a transaction on Friday, January 9th. The shares were sold at an average price of $70.00, for a total value of $455,000.00. Following the sale, the chief financial officer directly owned 111,713 shares of the company’s stock, valued at approximately $7,819,910. The trade was a 5.50% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 51,477 shares of company stock valued at $3,521,607. Insiders own 1.01% of the company’s stock.

Institutional Investors Weigh In On Docusign

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Centaurus Financial Inc. increased its holdings in Docusign by 2.6% in the second quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock worth $420,000 after buying an additional 136 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its stake in Docusign by 0.7% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock valued at $1,544,000 after acquiring an additional 149 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Docusign by 15.1% in the third quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock worth $89,000 after acquiring an additional 161 shares in the last quarter. Smartleaf Asset Management LLC grew its position in Docusign by 8.2% in the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock worth $166,000 after acquiring an additional 165 shares in the last quarter. Finally, Americana Partners LLC increased its stake in shares of Docusign by 3.3% during the 3rd quarter. Americana Partners LLC now owns 5,467 shares of the company’s stock worth $394,000 after purchasing an additional 176 shares during the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
• Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
• Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
• Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
• Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
• Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
• Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.